Dr. Paul Cheney, MD, PhD, is Medical Director of the
Cheney Clinic in Asheville, North Carolina.
For more than 25 years, Dr. Cheney has been a pioneering clinical researcher in the field of
ME/CFS and has been an internationally
recognized authority on the subject of ME/CFS.
He has published numerous articles and
lectured around the world on ME/CFS
. Dr. Cheney has been interested in many
aspects of ME/CFS, and is author or co-author of numerous publications and
scientific presentations in a range of fields relevant to the illness.
While practicing in Lake Tahoe in 1984-1987, Dr. Cheney, along
with Dr. Dan Peterson, helped lead a research effort with the NIH, the CDC and
Harvard University School of Medicine studying a localized outbreak of what
would eventually be known as ME/CFS.
was a founding Director of the American Association of CFS (now the
International Association for CFS/ME).
Dr. Cheney holds a PhD in Physics from
Duke University in Durham, NC and is a graduate (MD) of Emory University School
of Medicine in Atlanta, GA where he also completed his internal medicine
residency. He is a board certified internist.
More recently, Dr. Cheney has been engaged in investigating the cardiac
function of CFS patients, using Impedance Cardiography and Doppler
Echocardiography. According to his paper presented at the 2007 IACFS/ME
conference, "Chronic Fatigue Syndrome patients exhibit evidence of diastolic
dysfunction at a level well above that reported for control populations of the
same age. Energy dependent diastolic dysfunction would appear to be a hallmark
of CFS and supports the hypothesis that CFS is a syndrome of cellular energy
Since 1990, Dr. Cheney has headed the
Cheney Clinic, presently located in Asheville, NC. The Cheney Clinic
specializes in evaluating CFS patients and has expertise in diagnosis,
disability support for and treatment of chronic fatigue syndrome. No single
clinic has drawn as many CFS patients (currently over 5,000) from as many states
(48) and foreign countries (22) as has the Cheney Clinic.
The Cheney Clinic has evaluated over 8,000
patients from 48 states and 24 foreign countries and participated in an FDA-approved
multi-center , a biological response pharmaceutical drug trial using Ampligen, a
biological response modifier.